Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 889 of 1,261

  1. US 8354411

    1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound

    Takeda Pharmaceutical Company Limited · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  2. US 8354427

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  3. US 8354436

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  4. US 8354383

    6,11-bridged biaryl macrolides

    Enanta Pharmaceuticals, Inc. · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  5. US 8354549

    Method for preparing a polymer conjugate

    Nektar Therapeutics · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  6. US 8354390

    Compositions and methods for inhibiting expression of a gene from the ebola virus

    The United States of America as represented by the Secretary of the Army · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  7. US 8354115

    CD40 ligand adjuvant for respiratory syncytial virus

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  8. US 8354103

    Human antibodies to human angiopoietin-like protein 4

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  9. US 8354240

    VMP-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  10. US 8354450

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  11. US 8354538

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  12. US 8354477

    Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  13. US 8354446

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  14. AU 2011260614

    Oral dosage forms of bendamustine and therapeutic use thereof

    ASTELLAS DEUTSCHLAND GMBH [CH] · Granted Jan 10, 2013 · Expires Jan 5, 2033

    granted

  15. AU 2011260615

    Oral dosage forms of bendamustine

    ASTELLAS DEUTSCHLAND GMBH [CH] · Granted Jan 10, 2013 · Expires Jan 5, 2033

    granted

  16. US 8349892

    Solid formulations of prostacyclin analogs

    United Therapeutics Corporation · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  17. US 8349568

    Method of diagnosing poor survival prognosis colon cancer using let-7g

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  18. US 8349910

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  19. US 8349355

    Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields

    Anika Therapeutics S.r.l. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  20. US 8349838

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  21. US 8349899

    Selective inhibitors of EG5 motors and methods of use

    Arrowhead Center, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  22. US 8348921

    Gels with predetermined conductivity used in electroporation of tissue

    The Regents of the University of California · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  23. US 8349312

    Proline substituted cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  24. US 8349307

    Polymer conjugates of opioid antagonists

    Nektar Therapeutics · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.